Home › Small Cell Lung Cancer › Pennsylvania
Small Cell Lung Cancer clinical trials in Pennsylvania
15 studies for Small Cell Lung Cancer are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
- AHN Cancer Institute - Allegheny General, Pittsburgh
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT07472517A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- Sidney Kimmell Cancer Center - Jefferson Health, Philadelphia
RecruitingPhase 1
Ages 19 and older · All sexes · Updated Nov 5, 2026 · NCT06586957VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Cancer Care Associates of York (site 206), York
RecruitingPhase 1/2
Ages 18 to 80 · All sexes · Updated Nov 4, 2026 · NCT03556228AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Avenzo Therapeutics Recruiting Site, Philadelphia
RecruitingPhase 1/2
Ages 18 to 75 · All sexes · Updated Oct 16, 2026 · NCT07038343A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
- Consultants in Medical Oncology and Hematology, Broomall
- Alliance Cancer Specialists, Media
- Allegheny General Hospital, Pittsburgh
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 16, 2026 · NCT07218146Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- St. Luke's Physician Group - St. Luke's Cancer Care Associates, Fountain Hill
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 14, 2026 · NCT06712355The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
- University of Pittsburgh Medical Center, Pittsburgh
- WellSpan York Cancer Center, York
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Oct 2, 2026 · NCT04585750DESTINY-PANTUMOUR04
- Research Site, Philadelphia
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- St. Lukes University Hospital /ID# 280204, Bethlehem
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07365241Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
- Fox Chase Cancer Center, Philadelphia
- UPMC Hillman Cancer Center, Pittsburgh
- Guthrie, Sayre
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT07057791A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 9, 2026 · NCT07174583Tempus Small Cell Lung Cancer Observational Study (Sculptor)
- Cancer Care Association of York, York
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 15, 2026 · NCT05257551Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer
- Fox Chase Cancer Center, Philadelphia
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 22, 2026 · NCT05800587Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, Pittsburgh
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Mar 11, 2026 · NCT06681220Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- University of Pennsylvania, Philadelphia
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Feb 18, 2026 · NCT07030257From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.